Lecheng concentrates globally synchronised oncology drugs and clinical programmes — giving qualified patients access to targeted therapy, immunotherapy, and advanced radiation including innovations not yet available in mainland China. 樂城匯聚全球頂尖腫瘤藥械，患者可在此使用全球同步、國內尚未上市的前沿療法。
Targeted drugs matched to specific gene mutations — achieving individualised precision treatment with significantly improved outcomes and reduced side effects. 針對特定基因突變的靶向藥物，實現個體化精準治療，顯著提升療效並降低副作用。
Harnessing the immune system to target cancer — including CAR-T cell therapy, tumour vaccines, and other front-line immunotherapy programmes. 利用人體免疫系統對抗腫瘤，包括CAR-T細胞療法、腫瘤疫苗等前沿免疫治療方案。
State-of-the-art radiation therapy and interventional techniques that precisely target tumour cells while protecting healthy tissue. 採用最先進的放射治療設備與介入技術，精準消滅腫瘤細胞，保護正常組織。
Zone-pioneered precision interventional radiotherapy樂城先行地，精準介入放射治療
US technology — China's domestic first美國技術，中國內地首台
China's domestic first BNCT system中國內地首台BNCT系統
Precision radiotherapy protecting healthy tissue精準放射治療，保護正常組織
All treatments are executed by top Tier-3A hospitals with internationally recognised oncology departments. 依托中國頂級三甲醫院，提供最高水準的腫瘤診療服務。
* All programmes listed are nationally approved clinical translation applications, executed compliantly by top-tier tertiary hospitals. * 本頁所列項目均為已通過國家審批的臨床轉化應用項目，依托頂級三甲醫院合規執行。
Our team will assess your eligibility and connect you with the most suitable Lecheng oncology programme and institution.我們的團隊將評估您的資格，並為您匹配最合適的樂城腫瘤治療方案及機構。
REQUEST A CONSULTATION預約諮詢